1480OCTONG 1509: Phase III study of bevacizumab with or...

Annals of Oncology 2019 / 10 Vol. 30; Iss. Supplement

1480OCTONG 1509: Phase III study of bevacizumab with or without erlotinib in untreated Chinese patients with advanced EGFR-mutated NSCLC

Zhou, Q, Wu, Y-L, Cheng, Y, Liu, Y, Chen, G, Cui, J, Yang, N, Song, Y, Li, X-L, Lu, S, Zhou, J, Ma, Z, Yu, S-Y, Huang, C, Shu, Y
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz260.002
Date:
October, 2019
File:
PDF, 68 KB
2019
Conversion to is in progress
Conversion to is failed